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Over the past few years, considerable progress has been made in the identification 
of regulatory T  cell pathways and factors that act as mediators between T  cell subsets 
involved in these pathways (1-3). However, at least two important aspects of regula- 
tion of the immune response have remained largely unexplored. One of them is the 
role of antigen presentation and of major histocompatibility complex (MHC)1 restric- 
tion in the activation of suppressor T  (Ts) cells. From the paucity of reports on MHC 
restriction of Ts sets (4-8), one would conclude that MHC-restricted antigen presen- 
tation is not essential for the activation of most suppressor pathways. This view gains 
support from the demonstrated high affinity of some Ts cells for free antigen  (9-11). 
It is,  however, equally possible that  the uncertainties  about MHC  restriction  in Ts 
systems  reflect  the  absence  of  an  appropriate  experimental  model  in  which  the 
interaction of Ts cells with antigen-presenting cells (APC) could be explored. 
The second  aspect  that  appears to be neglected  is the  mechanism of interaction 
between Ts effector cells and their targets. The mode of action of suppressor-effector 
factors is largely unknown  (12-14), and, to our knowledge, there is only one report in 
the literature that bears on the direct interaction between Ts cells and T  helper (Th) 
cells (15). 
Our recent  work on the proliferative T  cell  response to lactate dehydrogenase  B 
(LDHB)  has provided a  system suitable to study the  questions  outlined  above. We 
have demonstrated (6-18)  that most H-2 haplotypes respond to LDHB and that the 
T  cell proliferation in all responder haplotypes is restricted by the molecule controlled 
by the A~ and A~ loci in the I-A region of H-2 (A [A~Aa] molecules). The proliferating 
cells are most likely Th cells because their genetic control is almost identical with that 
of antibody production to LDHB (16,  19). Nonresponder haplotypes to LDHB include 
virtually all strains that carry the k allele at the E~ and E~ loci of the H-2 complex. 
However, nonresponsiveness can be reversed by in vivo or in vitro administration of 
monoclonal antibodies against the molecule controlled by the E~ locus in the I-A and 
* Supported in part by grant Wa 139/No/A.I5 from the Deutsche Forschungsgemeinschaft. 
1 Abbreviations used in this paper:  A molecule, controlled by the A~ and A•  loci in the I-A region of H-2; 
APC, antigen-presenting cell; BudR, 5-bromo-2'-deoxyuridine;  E molecule,  controlled by the E  B locus in 
the I-A and the E~ locus in the I-E region of H-2; GA, poly(Glue'°Ala4°)  ; GAT, poly (Glu6°Alaa°Tyrl°);  GT, 
poly (GluS°TyrS°); KLH, keyhole limpet hemocyanin; LDHB, lactate dehydrogenase B;  MHC, major 
histocompatibility complex; SI, stimulation index; SRBC, sheep erythrocytes; Th, T helper cell; Ts, T 
suppressor cell; Tsel T suppressor effector; Tsi, T suppressor inducer. 
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the E~ locus in the I-E region of H-2 (E  k molecule). Furthermore, primed nonresponder 
T  cells depleted of Lyt-2-bearing cells give an A-restricted proliferative response upon 
challenge with  LDHB  in vitro  (16-18,  20).  The suppression observed in Ek-bearing 
nonresponder strains is LDHB specific, and expression of the E k molecule on the APC 
is necessary for its manifestation  (20).  Thus,  we have  a  system where  the target  of 
suppression is an A-restricted Th cell; the suppression can be measured as inhibition 
of Th cell proliferation, and at least one of the Ts cell subsets involved is E ~ restricted. 
The two main participating cell sets also differ in terms of their Lyt phenotypes. 
In this communication, we characterize the cells involved in the LDHB suppressor 
pathway  and  describe the interactions between  them,  with  particular emphasis on 
Ts-Th interaction. 
Materials  and  Methods 
Mice.  Female and male mice, 8-12 wk of age, were obtained from our colony at the Max 
Planck Institute for Biology. The strains used and their alleles at H-2 loci are listed in Tables 
III and VII. 
Antigens  and  Immunization.  Lactate  dehydrogenase  B4  (Boehringer,  Mannheim,  Federal 
Republic of Germany) and poly(GluS°Ala  4°) (GA; Miles-Yeda, Rehovot, Israel) were prepared 
and the immunizations were performed as described previously (16, 21). 
Antisera.  The  culture supernatants of hybridomas  1147  (anti-Lyt-  1.1) and  49-31.1  (anti- 
Lyt-2.1)  were a  gift from  Dr.  I.  F.  C.  McKenzie  (Department  of Pathology, University of 
Melbourne, Parkville, Victoria, Australia). Ascites fluids containing high-titered monoclonal 
antibodies were produced using the hybridomas  17/-27.R7  (anti-Ia.m5),  13/18  (anti-Ia.m7), 
H116-22.R7 (anti-H-2.ml), 19-178 (anti-Lyt-2.2) (22) (the hybridomas were obtained from Dr. 
G. J.  H~mmerling, German Cancer Research Center, Heidelberg, Federal Republic of Ger- 
many),  and  C3PO  (anti-Lyt-l.2, produced in  this laboratory). Anti-I-J  k alloantiserum was 
purchased from Cedarline, Hornby, Ontario, Canada. 
Cell Preparation.  Single cell suspensions prepared from the inguinal and  paraortic lymph 
nodes were passed through nylon wool columns; ~95% of the effluent cells were Thy-l.2  +, as 
detected by indirect immunofluorescence. Glass-adherent cells from peritoneal washings served 
as APC (23). 
Treatment of  Cells with Antibody and Complement.  Cells were treated with Lyt-specific antibodies 
and rabbit complement in a  one-stage test, as described previously (24).  Anti-I-J  k serum was 
used according to the producer's instructions. 
Preparative, Nonlytic Selection of Lyt Subsets.  Cells of the  Lyt-l+2  -  subset  were selected by 
incubation of T  cells with Lyt-2-specific antibody at 0°C  for  1 h, followed by incubation of 
cells on goat anti-mouse immunoglobulin (Ig) (Medac GmbH, Hamburg, Federal Republic of 
Germany)-coated  plastic  dishes  at  4°C  for  1  h  (25).  The  nonadherent  cells  were  >94% 
Lyt-l+2  -  (as assessed by indirect immunofluorescence with rat Lyt-speeific monoclonal anti- 
bodies). The adherent cells were further selected by incubation with Lyt-l-specifie antibody, 
followed by plating on fresh anti-mouse Ig-coated dishes. After this second plating, the adherent 
cells were ~98% Lyt- 1+2  +. 
Cell Cultures.  The culture medium was RPMI  1640  supplemented with 5%  horse serum, 
antibiotics, L-glutamine, and  2-mercaptoethanol (26).  Priming of T  cell subsets in vitro was 
carried out by culturing 4 ×  10  s cells/ml of T  cells with 1-2 ×  106 cells/ml of syngeneic APC 
in the presence of 15 btg/ml LDHB for 3 d, followed by incubation for 4 d without antigen. In 
some experiments, in vivo primed selected T cell subsets were restimulated in bulk culture with 
LDHB and fresh APC. 
Short-Term Incubation of Tse with Th or Tsi.  Lyt-1+2  +, J+ cells that had been primed in vivo 
(8 d) and restimulated in vitro (3 d) or primed and restimulated in vitro (8 +  3 d) were mixed 
in culture medium with Lyt-1  +2-, J-, or Lyt-1  +2- cells at ratios of 1:1 or 1:2 and incubated at 
37°C for 6 h. After incubation, the cell subset to be assayed was selected by Lyt-2 antibody plus 
rabbit complement (C)  (Lyt-l+2  -) or by positive selection with Lyt-2 antibody (Lyt-l+2+). 
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performed as described previously  (23).  Briefly, splenic T  cells were cultured  with allogeneic 
peritoneal  adherent  cells,  and,  after 3  d,  alloreactive cells were  removed  by  treatment  with 
5-bromo-2'-deoxyuridine  (BudR)  and light.  The surviving T  cells were  then  incubated with 
LDHn (15 gg/ml) and fresh allogeneic APC for 3 d  and without antigen for a  further 4 d. 
The  T  Cell Proliferation Assay.  This was performed as described previously (21). Monoclonal 
antibodies,  when  present,  were  included  in  the  same  volume  (0.2  ml)  of  culture.  Each 
experimental  group  was  set  up  in  3  to  15  parallel  cultures.  The  standard  deviation  rarely 
exceeded  10%.  The  results  are  expressed  as  ~  cpm,  that  is cpm  in  cultures  with  APC  plus 
LDHB minus cpm in cultures with APC, and stimulation index  (SI), that is, cpm in cultures 
with APC plus LDHB divided by cpm in cultures with APC. In experiments involving groups 
of different cell mixtures, A cpm and SI were determined for each individual cell mixture. 
Results 
The Ts Effector (Tse) Cell Is Lyt-l+2+,J +.  We have previously shown (16, 20) that 
primed T  cells from nonresponder mice, when depleted of Lyt-2-bearing ceils, can 
proliferate  upon  in  vitro  challenge  with  LDHB.  Thus,  at  least  one  T  cell  subset 
involved in  the suppression  of anti-LDHB  response  expresses  the Lyt-2  marker.  To 
characterize this subset, we separated different Lyt-subsets from nonresponder (C3H) 
mice by nonlytic selection and tested their mixtures for proliferation in a  secondary 
response.  The  results  in  Table  I  demonstrate  that  the  proliferating  cell  has  the 
Lyt-l+2 -, J-  phenotype.  The  proliferation  is  strictly  dependent  on  the presence  of 
both LDHB and APC and is restricted by the A k molecule, as shown by the blocking 
of  response  with  a  monoclonal  antibody  (anti-Ia.m5)  specific  for  this  molecule. 
Addition  of primed  Lyt-l+2 + cells  suppresses  the response  to background  level.  As 
was also shown previously (16, 17, 20), blocking of the E k molecule with Ia.m7-specific 
antibody abolishes suppression. Thus, the cell that suppresses the proliferation of Lyt- 
1+2  -  cells belongs to the Lyt-1 +2  + subset and requires the expression of E k molecules 
for its function. The results in Table I also demonstrate that the Lyt-1+2 + Tse carries 
cell-surface J  molecules. The Lyt-l-2 + subset, no matter whether J + or j-, primed in 
TABLE  I 
The  Tse Is an Lyt-l÷2+,J  + Cell 
Experi- 
ment 
T cell subsets from nonresponder (suppressed) 
C3H mice 
Subset 1  Subset 2 
Secondary proliferative response 
in the presence of 
1  Lyt-l+2  -*  None  APC +  LDHB 
Lyt- I +2-  None  LDHB 
Lyt-l+2  -  None  APC  +  LDHB  +  ala.m5 
(~A) 
Lyt-l+2  -  Lyt-l+2+:~  APC +  LDHB 
Lyt-l+2  -  Lyt-l+2  ÷  APC  +  LDHB  +  aIa.m7 
(aE) 
2  Lyt- 1+2  -, J-§  None  APC -4- LDH~ 
Lyt-l+2-,J  -  Lyt-l+2÷l]  APC +  LDHn 
Lyt-l+2  -, J-  Lyt-l+2  + (aJ  k +  C-treated)  APC +  LDHs 
Lyt-l+2-,J -  Lyt-l+2  + (C-treated)  APC +  LDHs 
lX cprn, SI 
29.410 (9.7) 
272 (1.1) 
502 (1.2) 
793 (3.3) 
18.273 (53.2) 
38.596 (21.2) 
388 (1.2) 
43.365  (23.7) 
-316 (0.8) 
* Primed in vitro after nonlytic selection with anti-Lyt-2.1 antibody. 
:~ Primed in vitro after double positive selection with anti-Lyt-2.1 and anti-Lyt-l.1 antibodies. 
§ In vivo primed cells selected by anti-Lyt-2.1 antibody and treated with anti-J  k +  C before culture. 
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vivo or in vitro, did not suppress the response (unpublished  data). Thus, these results 
identify an Lyt-l+2 +, J+ cell that suppresses the proliferative anti-LDHB  response of 
an Lyt-l+2 -, J-  (presumably Th)  cell. 
The Lyt-l+2  + Tse Is E  Restricted in Both  the Induction and the Effector Phase.  We have 
repeatedly  demonstrated  that  the  coating  of  the  E u  molecule  with  monoclonal 
antibodies prevents LDHmspecifie suppression  from occurring  (16-18,  20, and Table 
I).  We  have  also  shown  (20)  that  priming  of B10.A(2R)  (KkAkEkD~  T  cells  with 
LDH~  presented  on  APC  from  the  Ek-nonexpressor  strain  B10.A(4R)  (KkAkE°D ~) 
does not lead to suppression  (20). Taken together, these data provide strong evidence 
that recognition  of LDHB in the context  of E k molecules on APC  is required  for the 
generation of suppression. It has remained to be established which cells (and at what 
stage of their development) require antigen presentation in the context ofE k molecules. 
This question was partially addressed by the experiments in Table I and fully explored 
by  those  in  Table  II.  The  latter  data  show  that  blocking  of the  E  molecule  with 
antibody,  either  during  priming  of the  Lyt-l+2 +  cells,  or  at  their  effector  phase, 
abolishes suppression.  Antibodies  against class I  (K) or the class II (A) molecules are 
ineffective.  (The  A-specific antibody,  however,  blocks  the  proliferation  of Lyt-l+2 - 
cells; see also Table I). Thus, it is the Lyt-l+2 + Tse that requires antigen presentation 
in the context of E k molecules for both its induction  and its effector function. 
The  Interaction  between  Tse  and  Th  Cells  Is  Restricted  by  the  A  Region  of  the  H-2 
Complex.  We found in preliminary experiments that a short-term (6 h) incubation  of 
Th cells with Tse cells  (followed  by removal of Tse cells)  is sufficient  to abolish  the 
proliferation of Th cells in a  subsequen t  3-d assay. We have chosen  this technique  to 
investigate  the  genetics  of Th-Tse  interaction  because  it  eliminates  complicating 
allogeneic effects. Thus, Tse (Lyt-1+2 +) cells primed in vivo and restimulated  in vitro 
were  incubated  for 6  h  with  Th  (Lyt-l+2 -, J-)  cells  from  different  strains;  the  Tse 
cells were then killed with anti-Lyt-2 antibody and C, and the Th cells were tested for 
TABLE  II 
The Lyt-l+2  + Tse Is E Restricted at Both the Induction and the Effector Phase 
T  cell subsets from nonresponder (suppressed) C3H 
mice 
Subset L*  Subset 25 
Secondary proliferative response 
in the presence of 
A cpm, Sl 
Lyt-l+2 - primed in vivo  None  APC + LDHB  18.675 (12.8) 
None  Lyt-l+2 + primed in vitro  APC + LDHB  84 (1.1) 
Lyt-1  +2- primed in vivo  Lyt-1+2  + primed in vitro  APC + LDHB  -134 (0.9) 
Lyt- 1+2  - primed in vivo  Lyt-l+2 + primed in vitro  APC + LDHB + aIa.m7 (aE)  4.094  (4.9) 
Lyt-l+2 - primed in vivo  Lyt-l+2 + primed in vitro in  APC + LDHa  -184 (0.8) 
Lyt-l+2 - primed in vivo  the  presence  of aH-2.ml  APC + LDHB + aIa.m7 (aE)  9.331 (10.9) 
(aK) 
Lyt-l+2  -  primed in vivo  Lyt-l+2  + primed in vitro in  APC +  LDHB  -7  (1.0) 
Lyt-l+2  -  primed in vivo  the  presence  of  aIa.m5  APC +  LDHB + aIa.m7 (orE)  14.294 (18.1) 
(aA) 
Lyt-l+2  -  primed in vivo  Lyt-l+2  + primed in vitro in  APC +  LDHB  8.000 (20.0) 
Lyt-l+2-primedinvivo  the  presence  of  ~xIa.m7  APC  +  LDHB  +  aIa.m5  1.943(5.6) 
(aE)  (aA) 
* Obtained by treatment with anti-Lyt-2.1 +  C. 
$ Obtained by nonlytic double positive selection with anti-Lyt-2.1 and anti-Lyt-1.1 antibodies. 826  LACTATE DEHYDROGENASE B  SUPPRESSOR  PATHWAY 
antigen-specific  proliferation.  The  genetic  mapping  of  Tse-Th  cell  interaction  is 
summarized  in  Table  III.  The  data  demonstrate  the  following:  first,  the  non-H-2 
background  does  not  influence the  Tse-Th  cell  interaction  because  C3H  Tse  cells 
suppress C3H, CBA, and B10.BR Th  cells equally well.  Similarly, B10.AL Tse cells 
suppress both B10.AL and A.AL Th  cells. Second, the experiment with B10.AL Tse 
and Th  cells from  different  strains excludes  the  involvement of the K,  C, S,  and  D 
regions of H-2 in the control of the Tse-Th cell interaction. Furthermore, the failure 
of B 10.AL Tse cells to suppress B 10.D2 Th cells indicates that sharing of genes in the 
A,J, or E  regions is necessary for an effective Tse-Th cell interaction to occur. Third, 
the capability of B10.A(2R)  Tse cells to suppress  B10.A(4R)  Th  cells demonstrates 
that compatibility at the A region is sufficient for Tse-Th cell interaction. Collectively, 
these data map the genes that restrict Tse-Th cell interaction to the A  region. 
The Receptor of the Th Cell Determines the Restriction of Tse-Th interaction.  Because the 
Th cell is A  restricted, whereas the Tse cell is E  restricted, the A  restriction of the Tse- 
Th cell interaction is probably determined by the receptor of the Th cell. To test this 
hypothesis  experimentally, we  investigated  the capacity of Tse cells to  suppress  Th 
cells that  recognize LDHB  in the context  of allogeneic MHC  molecules.  The  latter 
cells  can  be  generated  by priming in  vitro  with  antigen on  allogeneic APC,  after 
removal  of alloreactive  T  ceils  with  BudR  and  light  treatment.  The  T  cells  thus 
generated  are restricted  by the allogeneic class II molecules of the APC  (23).  Using 
this system, we  generated  B10.A(2R)  Th  cells that  recognize  LDHB  on B10.S  APC 
TABLE III 
The Tse-Th Cell Interaction Is Restricted by the A Region of H-2 
Tb(Lyt- 1÷2  -, I-J-) cells* 
Strain 
Alleles at H-2 regions 
KAJECSD 
Proliferative  response of Th cells after contact with ~: 
Unprimed  Primed Lyt- 1+2  +*  Lyt- 1+2  + (control 
(Tse cells)  Tse cells) 
A cpm, S1 
C3H  C3H 
C3H  k  k  k  k  k  k  k  22 (1.0)  7.300 (6.8)  6.069 (5.8) 
CBA  k  k  k  k  k  k  k  332 (1.4)  7.507 (9.1)  9.005 (10.7) 
B10.BR  k  k  k  k  k  k  k  1.696 (1.6)  8.776 (4.1)  9.885 (4.3) 
B10.AL  B10.AL 
B10.AL  k  k  k  k  k  k  d  -532 (0.8)  10.123 (3.3)  12.067 (4.0) 
A.AL  k  k  k  k  k  k  d  -2.068 (0.6)  5.993 (2.1)  6.846 (2.2) 
B10.A  k  k  k  k  d  d  d  1.023 (1.2)  10.698 (3.1)  9.430 (2.9) 
A  k  k  k  k  d  d  d  -2.258 (0.6)  8.500 (2.5)  7.824 (2.3) 
B10.A(2R)  k  k  k  k  d  d  b  -3.177 (0.4)  9.111 (2.7)  9.231 (2.7) 
B10.TL  s  k  k  k  k  k  d  -1.468 (0.7)  9.107 (2.7)  11.766 (3.2) 
B10.D2  d  d  d  d  d  d  d  9.375 (3.9)  8.364 (3.7)  10.132 (3.5) 
B 10.A(2R)  B 10.A  (2R) 
B10.A(4R)  k  k  b  b  b  b  b  842 (1.4)  ND§  10.652 (6.5) 
* Cells were primed in vivo with LDHB and restimulated in vitro with LDHB on syngeneic APC. 
:~ Th cells were incubated with Tse cells for 6 h; Tse cells were then killed with anti-Lyt-2.1(C3H) or anti- 
Lyt-2.2 [B10.AL, BI0.A(2R)]  and C, and Th cells were tested  for proliferative  response to LDHB on 
syngeneic APC in a 3-d assay. 
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and  B10.S  Th  cells recognizing  LDHB  on  B10.A(2R)  APC  (Table  IV).  Both  cell 
populations were incubated with B 10.A(2R) Tse cells (Lyt-1+2  +) for 6 h, the Tse cells 
were then removed by anti-Lyt-2.2 and (2 treatment, and the Th cells were tested for 
antigen-specific  proliferation.  The  results  in  Table  IV  demonstrate  that  both  Th 
populations respond to LDHB on the priming allogeneic AP(2 but  do not  recognize 
the  antigen  on  syngeneic  APC.  Furthermore,  B10.A(2R)  Tse  cells  suppress  the 
response of B 10.S Th cells to LDHB on B 10.A(2R) APC but do not affect the response 
of syngeneic B10.A(2R)  Th cells to LDHn on B10.S  APC. Thus,  allogeneic Th  cells 
restricted by the MH(2 halplotype of Tse are suppressed, whereas the response of Th 
cells syngeneic to the Tse but restricted by allogeneic MH(2  are not  affected. These 
results demonstrate  that  the receptor and  not  the  MHC  haplotype of the Th  cells 
determines  their  capability  to  interact  with  Tse  cells.  The  most  straightforward 
(although  not  the  only  possible)  interpretation  of these  data  is  that  the  Th  cells 
recognize the Tse cells, and not vice versa. 
The Lyt-l+2+,J  + Tse Requires a Nonspecific Lyt-l+2-,J  + Ts-inducer  (Tsi)  Cell.  Thus 
far, the results have demonstrated that the Lyt-l+2  + Tse can be primed with LDHB 
presented by Ek-expressing AP(2 in the absence of other T  cell sets. This cell, therefore, 
seems to be more autonomous than the Tse of other suppressor systems, which require 
a  series of inductive cell interactions to become activated (3). We have, however, not 
ruled out  the possibility that  after antigen  priming, the Tse  receives an  additional 
signal  provided  by  the  Lyt-l+2  -  cells  in  secondary  cultures.  To  investigate  this 
possibility, we compared the ability of Tse cells to suppress Lyt-1 +2- and Lyt-1 ÷2-, J- 
(treated with anti-J  k +  C) cells, respectively. As seen in Table V  (and also in Table I), 
in  vivo  primed  Tse  are  capable  of suppressing  the  response  of  Lyt-l+2  -  and  of 
Lyt-l+2  -, J- cells equally well. In contrast, in vitro primed Lyt-l+2  + cells exert their 
suppressor  function  only in  the  presence of Lyt-l+2  -, J+  cells  (Table  V).  Thus,  to 
become  functional,  in  vitro  primed  Tse  requires  a  second  signal  provided  by  an 
Lyt-l+2  -, J+  Tsi  cell.  Because  Tse  from  immunized  mice  can  suppress  Th  in  the 
absence of Tsi, it is likely that in this case the Tsi-Tse interaction occurred in vivo. 
TABLE IV 
The Restriction Specificity of Th Cells Determines the Interaction between Th and Tse Cells 
In vitro priming of Th (Lyt-1+2  -)  Incubation of 
cells*  Th with 
B 10.A(2R) Tse 
Th ceils from  APC from strain  (Lyt-I÷2+) 
strain  cells~: 
Secondary proliferative response of Th cells 
to LDHB§ 
APC from strain  A cpm  SI 
B 10.A(2R)  B 10.S  -  B 10.S  14.362  3.7 
B  10.A(2R)  B 10.S  -  B 10.A(2R)  209  1.0 
B 10.A(2R)  B 10.S  +  B 10.S  1  l. 762  3.2 
B 10.S  B 10.A(2R)  -  B 10.A(2R)  10.133  5.4 
B 10.S  B 10.A(2R)  -  B 10.S  313  I. 1 
B 10.S  B 10.A(2R)  +  B 10.A(2R)  1.297  1.6 
B 10.S  B 10.A(2R)  +  B 10.S  -  180  0.9 
* Th cells were depleted of alloreactive cells by BudR  and light treatment and were then  primed with 
LDHB on allogeneic APC for 7 d. 
Th cells were incubated with in vivo primed irradiated Tse ceils for 6 h. The Tse cells were then killed 
with anti-Lyt-2.2 and C, and Th cells were tested for secondary proliferation. 
§ Response of 1 ×  105 Th cells to LDHB on  1 ×  10  s APC in a 3-d assay. Background cpm values for 
allogeneic APC were 5.692 (BI0.S) and 2.293 B10.A(2R). 828  LACTATE DEHYDROGENASE B  SUPPRESSOR  PATHWAY 
TABLE  V 
Requirement for a Ts-inducer Cell 
T cell subsets from nonresponder (suppressed)  C3H mice 
Subset  1"  Subset  25 
Secondary proliferative 
response to APC + 
LDHB 
A cpm, Sl 
Lyt-1+2  -  primed in vivo  None  59.105 (20.8) 
Lyt-1+2  -, J- primed in vivo  None  39.235 (12.5) 
None  Lyt-l+2  + primed in vivo  -1.218 (0.8) 
Lyt-l+2  -  primed in vivo  Lyt-l+2  + primed in vivo  1.709 (1.4) 
Lyt-1+2  -, J- primed in vivo  Lyt-1+2  + primed in vivo  6.139 (2.9) 
Lyt-l+2  -  primed in vivo  None  10.323 (14.8) 
Lyt-1+2  -  primed in vivo  Lyt-1+2  + primed in vitro  406 (1.4) 
Lyt-l+2  -, J- primed in vivo  Lyt-l+2  + primed in vitro  8.600 (10.6) 
* See footnotes to Table II. 
TABLE  VI 
The Tsi Cells Need Not Be Antigen Specific 
T cell subsets from nonresponder (suppressed)  B 10.A mice*  Secondary prolif- 
erative response to 
Tsi$  Tse§  Th$  LDHB +  APC 
A cpm, SI 
None  None  Lyt-l+2  -, I-J-  4594 (8.7) 
None  Lyt-l+2  + primed in vivo  None  53 (1.1) 
None  Lyt-1+2  + primed in vivo  Lyt-1+2 -, I-J-  626 (2.1) 
None  Lyt-1 +2 + primed in vitro  Lyt-1 ÷2-, I-J-  5027 (9.4) 
Lyt-l+2  -  LDHB-primed  None  Lyt-l+2  -, I-J-  5647 (10.4) 
Lyt-l+2  -  LDHB-primed  Lyt-l+2  + unprimed  Lyt-l÷2  -, I-J-  4935 (9.2) 
Lyt- 1  +2- GA-primed  Lyt- 1  +2  + unprlmed  Lyt- 1  +2-, I-J-  3497 (6.8) 
Lyt-l+2  -  LDHB-primed  Lyt-l+2  + primed in vitro  Lyt-l+2  -, I-j-  430 (1.7) 
Lyt- 1  +2- GA-primed  Lyt- 1  +2  + primed in vitro  Lyt- 1+2  -, I-J-  499 (1.8) 
Lyt-l+2  -  unprimed  Lyt-l+2  + primed in vitro  Lyt-l+2  -, I-J-  374 (1.6) 
* Tse  (obtained  by double positive  selection)  were first  induced  by  incubation  with Tsi  for  6 h,  then 
positively selected using anti-Lyt-2.2  antibody, and incubated with Th for another 6 h. After the second 
incubation Tse were killed with anti-Lyt-2.2  + C and Th were tested  for proliferation in a 3-d assay. 
:]: Primed in vivo with LDHs, unless indicated otherwise.  Obtained by treatment with anti-Lyt-2.2 + C. 
§ Primed with LDHB unless indicated otherwise. 
We investigated whether antigen  is required  for the activation of the Lyt-l+2 -, J+ 
Tsi cells. The results in Table VI show that  Lyt-l+2 -  cells from nonimmunized  mice 
or  from  mice  immunized  with  LDHB  or  GA  serve  equally  well  as  inducers  of the 
LDHB-specific Tse. Thus,  the Tsi cells in the LDHB system appear  to be nonspecific. 
Absence of Genetic Restriction  in the Interaction between Tsi and Tse Cells.  The short-term 
cell-mixing protocol applied for the studies of Th-Tse interaction  (Table III) was also 
used  to establish  the  genetic  requirements  for interaction  between  Tsi and  Tse cells 
(Table VII). Lyt-1+2 + Tse cells from B 10.AL mice were primed in vitro and incubated 
for  6  h  with  Lyt-l+2 -  (Tsi)  cells  from  different  strains.  The  Tse  cells  were  then 
positively selected with Lyt-2.2 antibody and incubated  for a  further 6  h  with primed 
syngeneic  Th  (Lyt-l+2 -, J-)  cells.  After  the  second  incubation,  the  Tse  cells  were 
killed  with  anti-Lyt-2.2  antibody  and  C,  and  the  Th  cells  were  tested  for  antigen- 
specific proliferation in a  3-d assay.  The data in Table VII demonstrate  that  the Tsi- Activation: 
Cells and 
interactions: 
C.  N.  BAXEVANIS,  N.  ISHII,  Z.  A.  NAGY,  AND J.  KLEIN 
Unknown  E molecule of  A molecule of 
(not antigen  APC LDHn  APC LDHB 
specific)  l  I 
unrestricted  A restricted, 
Tsi  ~ Tse  ~ Th 
induction  LDHa-specific 
Lyt- 1  +2-, J+  Lyt- 1  +2  +, J+  Lyt- 1  +2-, J- 
suppression 
FIG.  1.  The LDHs suppressor pathway. 
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Tse  cell  interaction  is  independent  of both  the  H-2  complex  and  the  non-H-2 
background; in other words, the interaction is unrestricted. 
Discussion 
Based on the data in this communication, the LDHB suppressor pathway can be 
summarized, as shown in Fig.  1. At first glance, this pathway appears to be different 
from other suppressor pathways described thus far, first, in its simplicity, second, in 
that the antigen must be presented to the Tse cell in the context of E molecules, and 
third, in the involvement of a  nonspecific Tsi cell. However, a closer analysis of the 
known suppressor pathways suggests that these differences may be more seeming than 
real. 
With regard to the first difference, we would like to point out that the suppressor 
pathways  involved  in  the  regulation  of  antibody  responses  to  SRBC  (1), 
poly(Glun°Alaa°Tyr  x°)  (GAT), poly(Glur~ryr  5°)  (GT)(2,  3),  and keyhole limpet he- 
TABL~  VII 
Lack of Genetic Restriction m  the Interaction  between  Tsi and Tse Cells 
Tsi (Lyt-l+2  -) cells* 
Secondary proliferation of BI0.AL Th 
cells (Lyt- 1  ÷2-, J-) after contract with:[: 
Alleles at H-2 regions  Primed BI0.AL,  Unprimed B10.AL, 
Strain  Lyt-l+2  ÷ cells§  Lyt-l+2  + cells 
KAJ  E  C  S  D 
ti cpm, SI 
B10.AL  k  k  k  k  k  k  d  -511  (0.4)  13.744  (17.1) 
A.AL  k  k  k  k  k  k  d  -2  (1.0)  13.342  (24.0) 
B10.A  k  k  k  k  d  d  d  -267 (0.7)  8.698 (15.1) 
A  k  k  k  k  d  d  d  158 (1.4)  5.506 (14.1) 
B10.TL  s  k  k  k  k  k  d  292 (1.4)  10.015  (13.0) 
A.TL  s  k  k  k  k  k  d  -132 (0.8)  13.958  (21.1) 
B10.TFR1  s  k  k  k  k  k  f  62 (1.1)  13.541  (13.8) 
A.TFR1  s  k  k  k  k  k  f  527 (1.9)  12.751  (28.3) 
B10.A(2R)  k  k  k  k  d  d  b  224 (1.3)  9.492 (12.2) 
C3H  k  k  k  k  k  k  k  876 (1.8)  12.257  (14.1) 
B10:S  s  s  s  s  s  s  s  316 (1.4)  12.958  (15.0) 
* Cells were primed in vivo with LDHa. 
:1: Tse cells were first induced by incubation with Tsi cells for 6 h, then positively selected and 
incubated with Th for another 6 h. After the second incubation, Tse cells were killed with 
anti-Lyt-2.2 and C, and Th cells were tested for proliferative response to LDHB on APC in 
a 3-d assay. 
§ Cells were primed in vitro with LDHB on APC. 830  LACTATE DEHYDROGENASE B SUPPRESSOR PATHWAY 
mocyanin (KLH) (26)  actually consist, as does the LDHB-specific pathway, of only 
two cells.  Although in two pathways, the GAT-specific and the SRBC-specific ones, 
a third Lyt-1-2  + cell has been implicated, it has not been determined whether it is a 
distinct cell, or whether it has arisen from the second, Lyt-l+2  + cell, by a phenotype 
change.  Thus,  all  known  regulatory pathways  of antibody responses appear to be 
bicellular, in contrast to the delayed-type hypersensitivity suppressor pathways that 
seem to involve three cells (2, 3). 
The second seemingly unique feature of the LDHB pathway is the requirement for 
the antigen to be presented to the Tse cells in the context of E molecules. It should be 
emphasized,  however,  that  in  all  pathways,  triggering  of the  second  cell  in  the 
pathway (Ts2) requires antigen  (1, 26-28)  in addition to the signal provided by TSl 
(Tsi) cells.  It is, therefore, conceivable that  antigen presentation may play a  role at 
the level of Ts2 induction, although this aspect has not yet been explored in the other 
systems. In fact, we found another example for E-restricted suppression in the immune 
response to IgG2a myeloma proteins (16).  Furthermore, it is possible that the mecha- 
nism behind the control of anti-GT response by two complementing Is genes (29)  is 
E-restricted suppression because the Is-gene complementation is very similar to that 
required for the cell-membrane expression of E molecules (30). 
The  third  difference between  the  LDHB  pathway  and  other  known  suppressor 
pathways  is that  the Tsi cell is nonspecific in  the former and  apparently antigen- 
specific in the latter. However, a  direct comparison of inducer cells in the pathways 
is hampered by the insufficiency of information on these cells.  For example, the Ysa 
cells in  the GAT, GT, and  KLH systems have not  yet been isolated.  The antigen 
specificity of inducer cells in the GAT, GT, and SRBC systems is extrapolated from 
the specificity of inducer factors extracted from lymphoid cells of immunized mice 
(28, 31, 32). Control experiments to test the inducer activity of Tsi cells cultured with 
an  unrelated  antigen  or without  antigen  have not  been reported.  These examples 
illustrate the prematurity of attempts at establishing similarities or differences between 
different suppressor pathways. 
Our data have also provided some information about the mechanisms of interac- 
tions between cells of the LDHB suppressor pathway. The mechanism by which Tsi 
cells activate Tse cells has not yet been studied in detail. It is, however, likely that this 
activation occurs via a nonspecific factor, which may be similar to interleukin 2 (33). 
This assumption is based on the observations that, first, the Tsi cell does not require 
specific activation by antigen; second, it acts on Tse cells after the latter have been 
primed;  and  third,  the  action  of Tsi  on  Tse cells  is  unrestricted.  The  interaction 
between Tse and Th cells is more difficult to visualize.  This interaction is antigen 
specific (20;  and C. Baxevanis, unpublished data)  and MHC  restricted (Table III). 
Because the interacting cells themselves are also antigen specific and MHC restricted, 
the interaction is not likely to be based on the recognition of idiotypic determinants. 
The  key information  for understanding  the  Tse-Th  cell  interaction  is  that  the  A 
restriction of this  interaction  is  dictated  by  the  receptor  (anti-A  k)  of the Th  cells 
(Table IV'). Thus, in terms of recognition, the active party is the Th and not the Tse 
cell.  Considering  also  that  the  interaction  is  antigen  specific and  A  restricted,  its 
simplest  mechanism  would  be a  concomitant  recognition of LDHB and  A  region- 
controlled molecules by Th cells on the surface of Tse cells.  This recognition would 
trigger a  suppressor mechanism,  for example, the production of a  short-range sup- C.  N.  BAXEVANIS, N.  ISHII, Z. A.  NAGY, AND J.  KLEIN  831 
pressor factor,  that  inactivates  the Th  cell.  The mechanism outlined  here requires, 
first, the recognition by Th and Tse of two different epitopes on the LDHB molecule 
(that is, formation of an antigen bridge), and second, the expression of A  molecules 
by Tse cells. We are presently investigating whether these two requirements are met. 
Summary 
We characterized the cell types involved in the H-2-controlled suppression of T  cell 
response to lactate dehydrogenase B (LDHB). The suppressor effector (Tse) was found 
to  be  an  Lyt-l+2  +, J+  cell  that  recognizes  antigen  together  with  E k molecules  of 
antigen-presenting cells (APC). To become functional, the Tse cell requires a second 
signal  from  a  nonspecific,  Lyt-l+2  -, J+  suppressor-inducer  (Tsi)  cell.  The  Tsi-Tse 
interaction is not subject to any genetic restriction. The target cell of suppression is an 
Lyt- 1  +2-, J-  (most likely T  helper [Th]) cell that recognizes LDHB in the context of 
A  molecules on  APC.  The suppression  is  manifested  in  inhibition  of the  antigen- 
specific, A-restricted proliferation of Th cells. The interaction between Tse and Th is 
restricted by the A region of the H-2 complex. Because this restriction is determined 
by the receptor of Th cells, the mechanism of Th-Tse interaction most likely involves 
a concomitant recognition of LDHB and A region-controlled molecules by Th cells on 
the surface of Tse cells. 
We thank Dr. G. J. H~mmerling and Dr. I. F. C. McKenzie for hybridomas and hybridoma 
antibodies, and Ms. Karina Masur for typing the manuscript. 
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